|Bid||11.45 x 1000|
|Ask||13.60 x 1200|
|Day's Range||11.11 - 12.17|
|52 Week Range||8.06 - 28.25|
|Beta (5Y Monthly)||-0.15|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 02, 2022 - Mar 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||31.25|
Viewing insider transactions for Repare Therapeutics Inc.'s ( NASDAQ:RPTX ) over the last year, we see that insiders...
CAMBRIDGE, Mass. & MONTREAL, September 07, 2022--Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate at two investor conferences in September. Details for the fireside chats are as follows:
It is doubtless a positive to see that the Repare Therapeutics Inc. ( NASDAQ:RPTX ) share price has gained some 42% in...